In the present retrospective cohort, p16 expression levels were significantly correlated with decreased CAV1 expression levels in penile tumor cells, which together with the decreased overall survival of CAV1-overexpressing tumors, would support the idea that p16-positive tumors could account for a better clinical outcome. The gene discussed is CAV1; the disease is penile neoplasm.